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Discussion
DrThomasA. D’Amico (Durham, NC). I congratulate both authors
for this thoughtful study that describes the incidence of nodules that
may have been missed at resection for lung cancer, a concept derived
from experience with thoracoscopic metastasectomy.
Just as with metastasectomy, it is possible that thoracoscopic ex-
ploration for resection of lung cancer will miss nodules, some of
which may be malignant. However, in this study, as in others, the
majority of missed nodules are benign. Regarding the malignant
nodules, the presence has been demonstrated, but the significance,
as you said, has not. I and others, I’m sure, are surprised that so
many of the nodules missed were 6 mm or larger, including all 3
of the noncarcinoid second primary lesions. One would expect
a 64-slice scanner to perform better.
Future studies are required to elucidate the significance of these
missed nodules in patients with both benign and secondary pulmo-
nary malignancy. It is possible that sequential thoracoscopic proce-
dures have a better outcome than thoracotomy in some patients,
depending on the biology of the tumor.
In light of your study and these comments, I have four questions.
What percentage of your patients underwent mediastinoscopy? You
found many more patients with N2 disease than with second primary
lesions.
Second, why did you not include thoracoscopic exploration as
part of your study to determine the true incidence of the missed nod-
ules? Thoracoscopic exploration may have found pleural or other
disease that would preclude thoracotomy.
Third, in this study, 14 of 166 patients had missed malignant
nodules. Of these 14, 9 of 14, or 5%, were thought to have M1 le-
sions. Five of those 9 already met criteria for adjuvant chemother-
apy. Thus only 4 patients, or 2%, had nodules that were found
that changed their therapy.
As well, 5 of 166 patients were thought to have second primary
tumors. Two of these 5 tumors were carcinoids, and although you
refute that they are tumorlets, by definition they are. Tumorlets are
carcinoids 5 mm or less that do not show up on CT scan, so by def-
inition these are tumorlets. One of the 5 was a pleura-based nodule
that you would have thought could have been found thoracoscopi-
cally. One of the 5 that you resected was actually N2. Therefore,
there is only 1 patient left with a second primary that definitely
can be said to have benefited, and it is not certain that a second
thoracoscopic procedure would have been less effective than that.
Finally, you found many more benign lesions than malignant
ones. Do you completely discount the potential negative effects of
these added resections?
I appreciate the authors for investigating these difficult issues.
Dr Cerfolio. Dr D’Amico, thank you very much. Four questions
but actually six sentences that require my comment. First of all, all
nodules were 6 mm or less, not 6 mm or greater. All nodules were 6
mm or less.
Second, you said that more patients had N2 disease. That is not
true. Twelve patients had N2. That’s 7%. That’s less than 14 patients
who had malignant disease.
Dr D’Amico. According to the manuscript, the majority were
6 mm or larger.
Dr Cerfolio. No, they were not. You can go back and look at
Table 2.
Dr D’Amico. I have your manuscript.
Dr Cerfolio. No, I’m talking about the nodules that we found at
the time of surgery. They were all 6 mm or less.
Dr D’Amico. As to the second issue, I said there were more with
N2 disease than second primary lesions. We would all argue that it is
important prognostically to find M1 disease, and no one would ar-
gue that it is not, but we are probably not going to affect the survival
of those patients, and, in fact, the original thoracotomy was a nega-
tive effect. However, more N2 disease was found than second
primary disease.
Dr Cerfolio. There were more N2 lesions found than second pri-
mary lesions, that’s true, but I do not know the clinical significance
of that. However, there were more patients who had malignant pul-
monary nodules than had unsuspected N2. You asked me when we
do mediastinoscopy. Well, as you know, any time a CT scan ques-
tions an N2 or an integrated PET/CT scan questions an N2, we do
mediastinoscopies. In this series, I think 38 or 40 patients got media-
stinoscopy. If any of them were positive, they were eliminated from
this study. All these were mediastinoscopy-negative. Actually, 1 of
them had a positive 4R, so it was a falsely negative mediastinoscopic
result. All the rest of them were in endoscopic ultrasound range. We
did not routinely use endoscopic ultrasound because of the prospec-
tive study we published in Chest in December 2006 (130:1791-5).
Your next question was about, by definition, what is a tumorlet.
By definition, a carcinoid tumorlet is a carcinoid not seen by CT
scan, less than 5 mm. Go back and look at the size in the table of
the carcinoids that were removed.
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Finally, you asked about the morbidity of removing benign nod-
ules. That is a very good question. I do think that because you are
using a Bovie electrocautery device (Bovie Medical Corporation,
St Petersburg, Fla), you are using a stapler, you are getting inflam-
mation in the part of the lung that you want to leave, and I do think
that there is morbidity in that. I think it is a very good point.
Dr D’Amico, we are on the same page. I think your comments
are great.
Dr Raja M. Flores (New York, NY). I think this is a very inter-
esting paper, but I would be very cautious about how you incorpo-
rate these data into your clinical practice. The implications are that
you should not be doing a VATS lobectomy because you would
miss lesions that you would otherwise find at thoracotomy. Then
you need to take it one step further: Do we do a sternotomy or bilat-
eral thoracotomy to palpate the contralateral lung? I think these data,
while interesting, need to be looked at a little more in depth.
Dr Cerfolio. That is the same comment that we hear all the time
about metastasectomies. If you believe that you are going to find
more nodules at the time of thoracotomy, why not explore both
sides? I would caution you and say that those data are looking at
the nodules in the same lung. We have no data that the incidence
is as high in the other lung, especially if the scan shows no nodules
there. So be careful not to assume that just because we find more nod-
ules when the CT scan shows 1 or more, we will find 1 nodule when
the CT shows none. I do not know of any data that would suggest to
just randomly explore a chest that has no evidence of a nodule.
Dr Nasser K. Altorki (New York, NY). You may have men-
tioned it already, but was there a correlation between the size of
the index lesion and the presence of these secondary nodules?
Dr Cerfolio. I tried to show that in one pie graph. I figured most
of these patients would have T2, larger lesions. They did not. Most
were T1. So 9 of these patients had T1 lesions, less than 3 cm, and
yet they had unsuspected malignant nodules.
Dr. Altorki. This is a pretty broad category. A 3-cm tumor and
a 1-cm tumor are clearly different.
Dr Cerfolio. You are right. I would have to go back and see the
exact size.
Dr Steven D. Herman (Brooklyn, NY). What do you think the
impact on the study outcome and conclusions would be of doing
the CT scans at 1-mm cut slices as opposed to 5-mm cuts, providing
higher resolutions of small lesions, or by repeating studies closer to
the surgery date if the studies are aged? Given the fast speed of CT
scanning available in 64-slice machines, this may offer more accu-
rate imaging.
Dr Cerfolio. Without studying it, I do not know the answer, but
my guess is that we would find more of these nodules. As Dr
D’Amico said, we are going to find a lot more benign nodules as
well. Then we are going to go to the operating room and do a right
thoracotomy. I will say in the operative note that there’s a 2-mm
nodule in the left upper lobe or 1-mm nodule in the left lower
lobe that I am assuming is benign, but I proceeded with resection.
I think we are going to see more of these.
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